Newsroom
Hear it from the FinVectorians
Stay informed with real-time updates on our innovations, corporate milestones, and industry insights.
Filter articles
Loading
A place to call home – Lotta Rissanen’s journey back to Kuopio and FinVector
Date 11.02.2025
Giuseppe Carloni and Jean-Frédéric Paulsen awarded with the Order of the Lion of Finland, 1st Class Knight’s Crosses
Date 05.02.2025
Exploring Finnishness – A FinVectorian’s Perspective
Date 06.12.2024
“There’s a lot of this vibrant atmosphere where innovation can happen” – Elisa Kajander’s journey at FinVector
Date 02.12.2024
FinVector welcoming applications for cooperation and support for 2025
Date 14.11.2024
A new global gene therapy manufacturing facility boosts healthcare innovation in Finland
Date 03.10.2024
Join FinVector as a Manufacturing Associate via Recruitment Training program
Date 26.08.2024
Savilahti blog: Kansainväliset rekrytoinnit vauhdittavat suomalaisen syöpälääkevalmistajan kasvua
Date 12.07.2024
From Brazil to Spain, and from Spain to Finland – Priscila Da Silva’s journey in biopharma at FinVector
Date 27.06.2024
Honorary recognitions from the academic frontier
Date 21.05.2024
The BioFinland Award 2024 granted to FinVector Oy
Date 11.04.2024
FinVector acquires two plots of land from the City of Kuopio
Date 27.03.2024
FinVector and UEF to further intensify collaboration
Date 14.03.2024
Become a Manufacturing Associate for FinVector via a Recruitment Training program
Date 01.12.2023
Innovation lives in our community
Date 13.11.2023
NIB to finance FinVector’s pharmaceutical gene therapy manufacturing
Date 07.06.2023
FinVector welcomes a New Managing Director to Kuopio
Date 11.04.2023
A Major Milestone for FinVector Following U.S. FDA Approval for Bladder Cancer Gene Therapy
Date 19.12.2022
FinVector rakentaa uuden viruspohjaisten geeniterapialääkkeiden tuotantoyksikön Kuopioon
Date 18.05.2022